Ganymed Pharmaceuticals GmbH;TRON - Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg - Universitaet Mainz gemeinnuetzige GmbH
发明人:
SAHIN Ugur,TURECI Ozlem,MITNACHT-KRAUS Rita,JACOBS Stefan Denis,UTSCH Magdalena Jadwiga,HEINZ Cornelia Adriana Maria,STADLER Christiane Regina,HEINZ Cornelia Adriana M
申请号：
SI201330741
公开号：
SI2852408T1
申请日:
2013.05.21
申请国别(地区):
SI
年份:
2017
代理人:
摘要：
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
